Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.
about
Skp2: a novel potential therapeutic target for prostate cancerHigh Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate CancerCaffeic acid phenethyl ester causes p21 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells.Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway.Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2.Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cellsAndrogens as therapy for androgen receptor-positive castration-resistant prostate cancer.Elevation of soluble guanylate cyclase suppresses proliferation and survival of human breast cancer cells.Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.AKT3 promotes prostate cancer proliferation cells through regulation of Akt, B-Raf, and TSC1/TSC2.Caffeic Acid phenethyl ester as a potential treatment for advanced prostate cancer targeting akt signalingCaffeic acid phenethyl ester suppresses proliferation and survival of TW2.6 human oral cancer cells via inhibition of Akt signalingCholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cellsIdentification of acetylation-dependent regulatory mechanisms that govern the oncogenic functions of Skp2.Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks.Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death.Androgen receptor differentially regulates the proliferation of prostatic epithelial cells in vitro and in vivo.Is DHT Production by 5α-Reductase Friend or Foe in Prostate Cancer?Combination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor-variants, and Akt in preclinical models: New hope for patients with castration resistant prostate cancer.Transient exposure to androgens induces a remarkable self-sustained quiescent state in dispersed prostate cancer cells.Increased acid ceramidase expression depends on upregulation of androgen-dependent deubiquitinases, USP2, in a human prostate cancer cell line, LNCaP.Saurolactam Inhibits Proliferation, Migration, and Invasion of Human Osteosarcoma Cells.Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study.Human castration resistant prostate cancer rather prefer to decreased 5α-reductase activity.Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase.From bench to bedside: bipolar androgen therapy in a pilot clinical study.Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions.A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers.Supraphysiological Testosterone Therapy as Treatment for Castration-Resistant Prostate Cancer.
P2860
Q24625558-0F64E0E9-57E3-4E99-890D-4597A075EFC3Q26774902-E25ECABE-035A-4546-BE30-BF1DE9D17A88Q34162761-C06476A2-7F94-4E0C-AAF3-0EC633422CE0Q34227242-591F7B61-4B53-4CB7-8C73-F21BBF570E54Q34278855-00F0614C-F6AE-4C0C-8E95-7404727F976CQ35070404-00EF98CE-7AB4-4246-B54D-3718BCB26C81Q35207110-29A31E6A-5A78-40BA-9AD0-448F02FD6C6DQ35558572-1FD520B4-4BE8-491B-A66F-4F931D26ACA9Q35740051-4C676DF5-D6ED-43AE-84AC-0CF7BF3294DFQ36413704-1BB64F0F-AA5E-4DCC-95ED-633ACC3B24ACQ36790229-36CC9789-DF51-4023-8AEB-87CAADBF33E5Q36913495-1E32980E-D17D-4AB6-B809-44267F0159D4Q36926791-EE206949-FD91-420B-9394-F2870837882FQ37030885-7A6CD5B2-D5DE-4D9F-949B-8FD56259899CQ37130094-2087A667-5D4B-42A6-93EB-09760CD8BAEFQ37322621-A96B6028-F821-4F10-A6BF-8200702989D4Q37688544-F79455C9-7EA7-4400-9154-A0276298ED81Q38256395-3CD3A7B1-5472-4E71-B983-345E1493925EQ38769775-02F9FD00-5621-46CC-B956-256BEEA921F1Q38828800-B7C8A75A-1248-45FE-884D-90B49DD59047Q38885436-713118AE-022C-4864-BA77-65F4E02ED4EEQ38915850-7EAB30C9-2F64-46F7-9016-28ABF9829245Q38922304-1A096099-37F1-4B43-8ED0-591F431E7FFCQ39190804-248BE3B5-1565-49C1-A8F8-D1E3B92ABAEDQ41839868-A8B06ABA-CC47-40B0-85CE-D9552341B38FQ42120157-56527D40-C3F2-40DC-901E-1350428256DAQ47359141-AD04CBE5-F465-45A5-86A4-DC38A96884B1Q47825566-227F79A2-F863-4A84-A8FE-7739E2918391Q55096243-B839B06B-895E-4428-BD1D-BA37B6B339EB
P2860
Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Androgen suppresses proliferat ...... gen receptor, Skp2, and c-Myc.
@ast
Androgen suppresses proliferat ...... gen receptor, Skp2, and c-Myc.
@en
type
label
Androgen suppresses proliferat ...... gen receptor, Skp2, and c-Myc.
@ast
Androgen suppresses proliferat ...... gen receptor, Skp2, and c-Myc.
@en
prefLabel
Androgen suppresses proliferat ...... gen receptor, Skp2, and c-Myc.
@ast
Androgen suppresses proliferat ...... gen receptor, Skp2, and c-Myc.
@en
P2093
P2860
P1433
P1476
Androgen suppresses proliferat ...... gen receptor, Skp2, and c-Myc.
@en
P2093
Chih-Pin Chuu
Ching-Yu Lin
Hui-Ping Lin
John M Kokontis
Junichi Fukuchi
Liang-Cheng Su
Richard A Hiipakka
Shutsung Liao
P2860
P304
P356
10.1111/J.1349-7006.2011.02043.X
P577
2011-08-18T00:00:00Z